This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Appelbaum, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Appelbaum, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2005, p. 2903-2913, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.2903-2913.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003

Ralf René Reinert,1* Susanne Reinert,2 Mark van der Linden,1 Murat Y. Cil,1 Adnan Al-Lahham,1 and Peter Appelbaum3

Institute of Medical Microbiology, National Reference Centre for Streptococci, University of Aachen (RWTH-Aachen), Aachen, Germany,1 SR Medical Communications GmbH, Frechen, Germany,2 Hershey Medical Center, Hershey, Pennsylvania3

Received 17 January 2005/ Returned for modification 11 February 2005/ Accepted 15 March 2005

Susceptibility testing results for Streptococcus pneumoniae isolates (n = 2,279) from eight European countries, examined in the PneumoWorld Study from 2001 to 2003, are presented. Overall, 24.6% of S. pneumoniae isolates were nonsusceptible to penicillin G and 28.0% were resistant to macrolides. The prevalence of resistance varied widely between European countries, with the highest rates of penicillin G and macrolide resistance reported from Spain and France. Serotype 14 was the leading serotype among penicillin G- and macrolide-resistant S. pneumoniae isolates. One strain (PW 158) showed a combination of an efflux type of resistance with a 23S rRNA mutation (A2061G, pneumococcal numbering; A2059G, Escherichia coli numbering). Six strains which showed negative results for mef(A) and erm(B) in repeated PCR assays had mutations in 23S rRNA or alterations in the L4 ribosomal protein (two strains). Fluoroquinolone resistance rates (levofloxacin MIC ≥ 4 µg/ml) were low (Austria, 0%; Belgium, 0.7%; France, 0.9%; Germany, 0.4%; Italy, 1.3%; Portugal, 1.2%; Spain, 1.0%; and Switzerland, 0%). Analysis of quinolone resistance-determining regions showed eight strains with a Ser81 alteration in gyrA; 13 of 18 strains showed a Ser79 alteration in parC. The clonal profile, as analyzed by multilocus sequence typing (MLST), showed that the 18 fluoroquinolone-resistant strains were genetically heterogeneous. Seven of the 18 strains belonged to new sequence types not hitherto described in the MLST database. Europe-wide surveillance for monitoring of the further spread of these antibiotic-resistant S. pneumoniae clones is warranted.

* Corresponding author. Mailing address: Institute of Medical Microbiology, National Reference Centre for Streptococci, University of Aachen, Pauwelsstrasse 30, D-52057 Aachen, Germany. Phone: 49 241 8089787. Fax: 49 241 808248. E-mail: Reinert{at}rwth-aachen.de.

Antimicrobial Agents and Chemotherapy, July 2005, p. 2903-2913, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.2903-2913.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Crosbie, P. A. J., Woodhead, M. A. (2009). Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J 33: 171-181 [Abstract] [Full Text]  
  • Mahdi, L. K., Ogunniyi, A. D., LeMessurier, K. S., Paton, J. C. (2008). Pneumococcal Virulence Gene Expression and Host Cytokine Profiles during Pathogenesis of Invasive Disease. Infect. Immun. 76: 646-657 [Abstract] [Full Text]  
  • Avrain, L., Garvey, M., Mesaros, N., Glupczynski, Y., Mingeot-Leclercq, M.-P., Piddock, L. J. V., Tulkens, P. M., Vanhoof, R., Van Bambeke, F. (2007). Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. J Antimicrob Chemother 60: 965-972 [Abstract] [Full Text]  
  • Homma, T., Hori, T., Sugimori, G., Yamano, Y. (2007). Pharmacodynamic Assessment Based on Mutant Prevention Concentrations of Fluoroquinolones To Prevent the Emergence of Resistant Mutants of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51: 3810-3815 [Abstract] [Full Text]  
  • Wierzbowski, A. K., Nichol, K., Laing, N., Hisanaga, T., Nikulin, A., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G. (2007). Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). J Antimicrob Chemother 60: 733-740 [Abstract] [Full Text]  
  • Schaaf, B., Kruse, J., Rupp, J., Reinert, R. R., Droemann, D., Zabel, P., Ewig, S., Dalhoff, K. (2007). Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia. Eur Respir J 30: 517-524 [Abstract] [Full Text]  
  • Shin, J. H., Jung, H. J., Kim, H. R., Jeong, J., Jeong, S. H., Kim, S., Lee, E. Y., Lee, J. N., Chang, C. L. (2007). Prevalence, Characteristics, and Molecular Epidemiology of Macrolide and Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae at Five Tertiary-Care Hospitals in Korea. Antimicrob. Agents Chemother. 51: 2625-2627 [Abstract] [Full Text]  
  • Martin, M., Quilici, S., File, T., Garau, J., Kureishi, A., Kubin, M. (2007). Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance. J Antimicrob Chemother 59: 977-989 [Abstract] [Full Text]  
  • van der Linden, M., Al-Lahham, A., Haupts, S., Reinert, R. R. (2007). Clonal Spread of mef-Positive Macrolide-Resistant Streptococcus pneumoniae Isolates Causing Invasive Disease in Adults in Germany. Antimicrob. Agents Chemother. 51: 1830-1834 [Abstract] [Full Text]  
  • LaPlante, K. L., Rybak, M. J., Tsuji, B., Lodise, T. P., Kaatz, G. W. (2007). Fluoroquinolone Resistance in Streptococcus pneumoniae: Area Under the Concentration-Time Curve/MIC Ratio and Resistance Development with Gatifloxacin, Gemifloxacin, Levofloxacin, and Moxifloxacin. Antimicrob. Agents Chemother. 51: 1315-1320 [Abstract] [Full Text]  
  • Sidhu, A. B. S., Sun, Q., Nkrumah, L. J., Dunne, M. W., Sacchettini, J. C., Fidock, D. A. (2007). In Vitro Efficacy, Resistance Selection, and Structural Modeling Studies Implicate the Malarial Parasite Apicoplast as the Target of Azithromycin. J. Biol. Chem. 282: 2494-2504 [Abstract] [Full Text]  
  • Rahman, M., Hossain, S., Shoma, S., Rashid, H., Baqui, A. H., van der Linden, M., Al-Lahham, A., Reinert, R. R. (2006). Emergence of a Unique Multiply-Antibiotic-Resistant Streptococcus pneumoniae Serotype 7B Clone in Dhaka, Bangladesh. J. Clin. Microbiol. 44: 4625-4627 [Full Text]  
  • Sogstad, M. K. R., Hoiby, E. A., Caugant, D. A. (2006). Molecular Characterization of Non-Penicillin-Susceptible Streptococcus pneumoniae in Norway.. J. Clin. Microbiol. 44: 3225-3230 [Abstract] [Full Text]  
  • Chen, Y.-Y., Yao, S.-M., Chou, C.-Y., Chang, Y.-C., Shen, P.-W., Huang, C.-T., Su, H.-P., Li, S.-Y. (2006). Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003.. J Med Microbiol 55: 1109-1114 [Abstract] [Full Text]  
  • Brandileone, M.-C. C., Casagrande, S. T., Guerra, M.-L. L. S., Zanella, R. C., Andrade, A.-L. S. S., Fabio, J.-L. D. (2006). Increase in numbers of {beta}-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.. J Med Microbiol 55: 567-574 [Abstract] [Full Text]  
  • Ip, M., Chau, S. S. L., Chi, F., Qi, A., Lai, R. W. M. (2006). Rapid Screening of Fluoroquinolone Resistance Determinants in Streptococcus pneumoniae by PCR-Restriction Fragment Length Polymorphism and Single-Strand Conformational Polymorphism.. J. Clin. Microbiol. 44: 970-975 [Abstract] [Full Text]  
  • Al-Lahham, A., De Souza, N. J., Patel, M., Rene Reinert, R. (2005). Activity of the new quinolones WCK 771, WCK 1152 and WCK 1153 against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes. J Antimicrob Chemother 56: 1130-1133 [Abstract] [Full Text]  
  • Naveau, C, Houssiau, F A (2005). Pneumococcal sepsis in patients with systemic lupus erythematosus. Lupus 14: 903-906 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»